Influence of a 100-km ultra-marathon on hepatitis B carrier runners

Y. H. Chiu, S. K. Hou, C. K. How, L. H. Li, W. F. Kao, C. C. Yang, S. L. Chou, Y. T S Shiau, C. Lam, R. J. Chen

研究成果: 雜誌貢獻文章同行評審

18 引文 斯高帕斯(Scopus)


This study compares the serological markers between runners who are hepatitis B virus carries (HBVc) and runners who are non-HBVc in a 100-km ultra-marathon race. Blood samples of 8 HBVc and 18 non-HBVc runners were drawn 1 week before, immediately following, and 24 h after the race. Samples were analyzed and compared between the 2 groups for liver function tests, muscle damage markers and oxidative stress cytokines. For HBVc runners, HBV-DNA (hepatitis B virus-deoxyribonucleic acid) levels were also evaluated for virus reactivation. The results demonstrate a statistically significant increase in both immediate and 24-h post-race values for alanine aminotransferase (ALT), aspartate aminotransferase (AST), lactate dehydrogenase (LDH), creatine kinase (CK), high-sensitivity C-reactive protein (hs-CRP), interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α), compared with pre-race values. No statistically significant difference was observed between the 2 groups for the values of AST, LDH, CK, hs-CRP, IL-6 and TNF-α either before or after the race. There was also no statistically significant change in the levels of HBV-DNA in HBVc runners. These findings suggest that HBVc runners do not have higher risks of liver function impairment, muscle breakdown and inflammatory response compared to non-HBVc runners in such endurance races.

頁(從 - 到)841-845
期刊International Journal of Sports Medicine
出版狀態已發佈 - 2013

ASJC Scopus subject areas

  • 骨科和運動醫學
  • 一般醫學


深入研究「Influence of a 100-km ultra-marathon on hepatitis B carrier runners」主題。共同形成了獨特的指紋。